Spinal cord infarction (SCI) is often disabling, and the diagnosis can be challenging without an inciting event (eg, aortic surgery). Patients with a spontaneous SCI are often misdiagnosed as having transverse myelitis. Diagnostic criteria for SCI are lacking, hindering clinical care and research.
S pinal cord infarctions (SCI) cause acute myelopathy with high morbidity. 1 A confident diagnosis is challenging without an inciting event such as a surgical procedure.
2
Onset is more protracted and radiologic distinction from competing diagnoses is more difficult than with cerebral infarction. Thus, patients with a spontaneous (ie, nonprocedural, nontraumatic) SCI often receive misdiagnoses. Although generally considered rare, 3 recent literature suggests underdiagnosis of spontaneous SCI, with 2 large studies showing 14% to 16% of patients referred for the evaluation of transverse myelitis ultimately are diagnosed as having SCI. 4, 5 Misdiagnosis may expose patients to unnecessary and possibly deleterious treatments, as well as missed treatment opportunities and secondary stroke prevention. Moreover, the lack of diagnostic criteria hinders progress in the field of SCI. Based on an analysis of 75 cases of periprocedural SCIs, 2 we applied insights from these definite cases to spontaneous SCI to better characterize its clinical, laboratory, and radiologic features and ultimately propose criteria for diagnosis of SCI.
Methods

Standard Protocol Approvals, Registrations, and Patient Consents
The study was approved by the institutional review board of Mayo Clinic, Rochester, Minnesota. All patients provided written consent to the use of their medical records for research.
Patients and Inclusion Criteria
We used an institution research tool to identify patients with a spontaneous SCI evaluated at Mayo Clinic, Rochester, Minnesota, from January 1, 1997, to December 1, 2017. We searched clinical notes in the Impression and Diagnosis sections for the terms spinal cord infarction, spinal cord stroke, anterior spinal artery, posterior spinal artery, and vascular myelopathy. We subsequently reviewed the data of all patients to verify the diagnosis. None of the included cases had spinal cord trauma, compression, or a recent procedure within 1 month. Inclusion criteria were final diagnosis of spontaneous SCI and adequate clinical (clear timeline and specificity of deficits, appropriate alternative etiologies excluded) and radiologic data (neuroimaging consistent with SCI and/or rule out alternative etiologies). Patients with periprocedural SCI were excluded but are reported elsewhere. 2 Furthermore, we excluded 46 patients in whom SCI was suspected but had incomplete data per our inclusion criteria.
Myelopathy Diagnostic Evaluation
The 
Cerebrospinal Fluid Evaluation
Cerebrospinal fluid evaluations included white blood cell count and differential, red blood cell count, protein, and glucose. Additional CSF testing included IgG index, oligoclonal bands, cytology, flow cytometry, Gram stain, bacterial culture, venereal disease research laboratory, Lyme disease serology and polymerase chain reaction (PCR), cryptococcal antigen, angiotensin-converting enzyme, paraneoplastic autoantibody evaluation, varicella-zoster virus PCR, Epstein-Barr virus PCR, cytomegalovirus PCR, enterovirus PCR, mycobacterium tuberculosis PCR, and culture.
Neuroimaging
Mayo Clinic neuroimaging was performed with 1.5-and 3-T magnetic resonance imaging (MRI) Siemens and General Electric machines. Neuroimaging prior to Mayo Clinic evaluation varied. Images from other diagnostic centers were reviewed and compared with Mayo Clinic MRIs. Typical Mayo Clinic MRI sequences included sagittal T1, T2, short-τ inversion recovery, and axial T2 sequences. Gadolinium was administered at the discretion of ordering and performing services. Diffusionweighted imaging (DWI) of the spine was not routinely performed. Imaging findings were documented according to initial appearance, with day 0 considered the initial day of deficit onset. The conus medullaris was defined as the very distal end of the spinal cord below the level of the lumbosacral enlargement. Meaning The validation of spinal cord infarction diagnostic criteria supports their utility.
Other Diagnostic Evaluation
computed tomography angiography), thoracoabdominal computed tomography angiography, full spinal magnetic resonance angiography, digital subtraction angiography, and electromyography/nerve conduction studies.
Clinical Evaluation
Records were reviewed to verify clinical details, neuroimaging findings, and confirm the diagnosis. All patients were seen by Mayo Clinic consulting physicians. Forty-five patients from this series were included in previous studies, 1, 5 and a subset of 15 patients with posterior spinal artery infarctions were included in a brief report elsewhere. 34 Time of onset was delineated by the initial neurological deficit (eg, weakness), not the onset of pain. Disability was measured by the American Spinal Injury Association Impairment Scale 6 and ambulatory outcomes. Descriptive analyses were performed using JMP Pro 13 (SAS Institute Inc).
Validation Cohort
For validation of the proposed SCI diagnostic criteria, we retrospectively analyzed a cohort of 280 adult patients from our institution with alternative intrinsic myelopathy etiologies selected from a myelopathy database. 
Results
Patient Demographics
We identified 133 patients 18 years and older with a spontaneous SCI; 71 (53%) were women, and 124 (93%) were white. Median (interquartile range [IQR]) age at presentation was 60 (52-69) years and 52 (39-61) years for patients with suspected fibrocartilaginous embolism. Median (IQR) time from symptom onset to evaluation at our facility was 18 (3-217) days; 77 patients (58%) were evaluated at our facility within the first 31 days. Median (IQR) follow-up was 1 (1-19) month.
Clinical Features
Spontaneous SCI presented with rapid severe deficits (eg, paralysis) (102 patients [77%] nadir within 12 hours) ( Table 1) ; 31 patients (23%) had a more prolonged time to nadir; however, all but 1 patient had a component of rapid decline with severe deficits within 12 hours. Selective pain and temperature sensory loss was present in 49 of 126 patients (39%). Severe back/limb pain was reported at onset in 96 patients (72%). A specific physical maneuver (eg, lifting, Valsalva) was described at or proceeding onset in 33 patients (25%). Clinical features are shown in Table 1 .
Vascular Risk Factors
A history of 1 or more vascular risk factors was present in 101 patients (76%): hypertension, 61 (46%); smoking, 61 (46%); hyperlipidemia, 57 (43%); and diabetes mellitus, 21 (16%). Cooccurring vascular disorders included coronary artery disease, 14 (11%); peripheral vascular disease, 10 (8%); atrial fibrillation, 8 (6%); and previous cerebral ischemia, 3 (2%).
Cerebrospinal Fluid Analysis
A lumbar puncture from the acute evaluation was available in 89 patients (66.9%) with the following abnormalities: elevated nucleated cell count (>5 cells/mcL), 7 (8%) (median, 14; range, 6-21; neutrophilic predominance, 3; monocytic, 1; lymphocytic, 1; unknown, 2); elevated protein (>35 mg/dL), 66 (74%) (median, 57; range, 36-655); supernumerary oligoclonal bands (≥3 supernumerary bands), 2 (2%); and elevated IgG index, 1 (1%). None had findings consistent with a specific infection, autoantibodymediated myelopathy, or other etiology.
Neuroimaging
Magnetic resonance imaging spine findings were available in 126 patients (94.7%) (1. a Median (interquartile range), 18 (0-3720) days after onset.
Research Original Investigation Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria
not have an MRI owing to a contraindication (eg, pacemaker, unstable condition). An intrinsic spinal cord lesion was demonstrated on MRI in all but 1 patient who had a normal MRI finding day 1 (flaccid paraplegia associated with aortic dissection). Thirty patients (24%) initially had a normal MRI result despite severe deficits (median day, 0; range day, 0-1). Subsequent imaging revealed T2-hyperintense cord lesions (median day, 4); 3 of these patients had acute DWI/apparent diffusion coefficient imaging, and 1 demonstrated restriction. The lesion axial localization and imaging pattern varied over the length of the lesion; a single infarct could have multiple patterns. The neuroimaging findings are shown in Table 2 . The posterior one-third of the spinal cord was involved on 1 or more imaging slices in 57 patients (45%). Five patients with gadolinium enhancement and follow-up imaging available 1 to 3 months after SCI had resolution of enhancement (median, 2.5; range, 1.5-2.5 months). Focal cystic myelomalacia with bright T2-hyperintense signal accompanied by T1 hypointensity was seen in 31 of 82 cases (38%) on follow-up imaging ( Figure 1 ). Vascular imaging (computed tomography angiography/ magnetic resonance angiography/digital subtraction angiography) was performed in 82 patients and revealed a specific 
Additional Diagnostic Evaluations
Ambulatory 24-hour Holter monitor was performed in 18 patients, and no specific contributing arrhythmia was identified. An echocardiogram in 52 patients (transesophageal, 35; transthoracic, 17) revealed the following findings: patent foramen ovale, 10; atrial enlargement, 3; Lambl excrescence, 2; spontaneous echo contrast, 1; atrial septal aneurysm, 1.
The following laboratory values were evaluated and abnormal: hemoglobin A 1C (>5.6%; to convert to proportions of total hemoglobin, multiply by 0.01), 10 of 21 patients (48%); elevated low-density lipoprotein (>100 mg/dL; to convert to millimoles per liter, multiply by 0.0259), 29 of 55 patients (53%); hypercoagulable profile, 7 of 63 patients (11%) (antiphospholipid antibody positivity, 4; heterozygous prothrombin gene mutation, 2; low antithrombin, 1); connective tissue disease evaluation, 11 of 78 patients (14%) (mildly elevated antinuclear antibody, 10; cyclic citrullinated peptide elevation, 1); anti-neutrophil cytoplasmic antibody panel for vasculitis, 2 of 45 patients (4%) (both perinuclear anti-neutrophil cytoplasmic antibody positive); paraneoplastic autoantibody evaluation, 8 of 44 patients (nonspecific low titer elevations of no clinical significance in all). Aquaporin-4-IgG was negative in 54 patients evaluated. Electromyography/nerve conduction studies were performed in 19 patients, with neurogenic changes (large motor units, fibrillations) correlating to the area of ischemia in 13 of 19 patients (68%).
Suspected Mechanism of Infarction
The suspected mechanism of SCI was idiopathic with atherosclerotic risk factors, 91 (68%); fibrocartilaginous embolism, 19 (14%); aortic dissection, 7 (5%); hypercoaguability, 5 (4%); vertebral artery dissection, 4 (3%); systemic hypotension, 3 (2%); cardioembolic, 2 (2%); and vasculitis, 2 (2%).
Treatment
Immunotherapy was used for a suspected immune-mediated condition in 74 patients (56%): corticosteroids, 71; intravenous immunoglobulin, 16; plasma exchange, 12; azathioprine, 1; mycophenolate mofetil, 1; and rituximab, 1. Blood pressure augmentation was used in 9, lumbar drain in 8, and intravenous tissue plasminogen activator was administered to 2 patients. Anticoagulation was initiated in 11 patients, and at least 1 antiplatelet agent was used in 92 patients. Other treatments for suspected alternative diagnoses included spinal decompression, 3 (all patients worsened after surgery); cardiac stent placement, 1; and epidural corticosteroid injection for radiculopathy, 1.
Outcomes and Follow-up
At final follow-up at our facility, American Spinal Injury Association Impairment Scale outcomes were graded as follows: A, 12; B, 5; C, 23; and D, 93. Ambulatory outcome at last follow-up was: no gait aid, 63 (47%); cane, 13 (10%); walker, 20 (15%); wheelchair, 34 (26%); and death, 3 (2%). No patients developed recurrent episodes of SCI during follow-up.
Proposed Diagnostic Criteria
We propose diagnostic criteria for SCI in the Box, using the terms definite, probable, and possible SCI. Patients in our study met the following criteria: definite, 39 (29.3%); probable, 83 (62.4%); and possible SCI, 10 (7.5%). One patient did not meet diagnostic criteria, having severe pain without significant deficits.
Validation Cohort
Of 280 patients from our validation cohort, 9 patients (3.2%) met criteria for possible SCI at presentation, but diagnostic evaluation revealed an alternative diagnosis was more likely in all: spinal dural arteriovenous fistula, 5 (MRI flow voids); multiple sclerosis, 2 (multiple demyelinating lesions on MRI); sarcoidosis, 1 (inflammatory CSF, enhancement pattern); and cytomegalovirus, 1 (inflammatory CSF). No patients met criteria for definite or probable SCI.
Discussion
We describe the clinical and neuroimaging details of a large series of spontaneous SCIs, propose diagnostic criteria, and use 
Research Original Investigation Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria
a validation cohort to assess their utility. Features often considered to be atypical (eg, >4 hours to nadir, MRI and clinical evidence outside the anterior spinal artery territory, gadolinium enhancement) are actually common and should not preclude physicians from making the diagnosis of SCI. Spinal cord infarction is underrecognized and frequently misdiagnosed as transverse myelitis, 4,5 highlighting the need for diagnostic criteria that can be broadly applied to patients with spontaneous and periprocedural SCI. The proposed SCI diagnostic criteria emphasize 3 major components: (1) clinical: rapid development of severe deficits within 12 hours; (2) MRI spine: exclusion of compression (2A) with supportive features (2B), and specific imaging findings (2C); and (3) CSF: highlighting noninflammatory findings in most. The most critical component is the rapid accumulation of severe deficits within 12 hours because more gradual worsening favors alternative etiologies. In our validation cohort, this was the most powerful diagnostic discriminator, similar to what others have found 4 ; it is rare for alternative myelopathy etiologies to present this rapidly with a severe deficit. A noninflammatory CSF profile is helpful to differentiate from infectious and inflammatory etiologies, although mild abnormalities might be encountered in SCI as seen in 8% of our patients. As with most other diagnostic criteria, a patient should not have a more likely alternative diagnosis ( eBo x1intheSupplement) based on the careful interpretation of all diagnostic information. Our validation cohort with only 9 patients (3.2%) initially meeting criteria for possible SCI suggests these criteria will be very helpful in discriminating SCI from other myelopathy etiologies. In addition, the criteria may have utility for enrollment in clinical trials and consensus of definitions for research in SCI.
Many prior cases of SCI have demonstrated a prolonged time to nadir over many hours, including autopsy-proven cases and periprocedural SCI.
2,4,9 The slower evolution of deficits than in cerebral infarction might be explained by diverse collateralization of spinal arterial supply 10 with transient preservation of tissue viability before infarction, while the relatively small area of the spinal cord may also make it more susceptible to the effects of edema contributing to clinical worsening. 11, 12 Pain was common at presentation (72%); it may be explained by SCI activation of the spinothalamic tract or by the contributing mechanism (fibrocartilaginous embolism, artery dissection). 9, 13, 14 Given the high proportion of older patients with vascular risk factors in our study, traditional stroke mechanisms (atherothrombosis) likely have an important role in SCI, 15 which may likely affect more proximal arteries than the spinal arteries themselves. 16 Cervical artery dissections may be underdiagnosed given limitations of assessment with standard angiographic imaging techniques; T1 fat suppression imaging may visualize a vessel wall hematoma ( Figure 2 ) and confirm a dissection. 17 Detection of local disc protrusions may suggest a fibrocartilaginous embolism as the mechanism of SCI, 9 which is still captured within and consistent with our diagnostic criteria; however, degenerative disc disease is very common in the general population. 18 Although some MRI features confirm SCI (criterion 2C), these features are often absent or sequences to detect these findings are not undertaken. Physicians should request DWI in patients with acute myelopathy in an attempt to confirm the diagnosis of SCI; however, DWI has incomplete sensitivity in SCI given limitations of spatial resolution and susceptibility artifacts, as has been shown in definite cases of periprocedural SCI. (Figure 2 ), highlighting the most predominant ischemic area (gray matter, arterial territory), and such a pattern is unusual with inflammatory etiologies. Other patterns of enhancement should lead clinicians to alternative diagnoses. When SCI remains in question after initial evaluation, follow-up imaging demonstrating chronic focal cystic myelomalacia (Figure 1 ) supports vascular sequelae as opposed to myelitis. 22 Unfortunately, no therapies are proven as effective to treat spontaneous SCI.
23, 24 Lumbar drainage and blood pressure augmentation are used for SCI in the setting of aortic surgery, 23, 25, 26 but there are no data to support these strategies in spontaneous SCI. Although previous cases 15 and 2 of these patients received intravenous tissue plasminogen activator without harm, there is no evidence for efficacy in SCI. Empirical intravenous methylprednisolone treatment is reasonable when concern remains for a possible inflammatory myelopathy. However, some treatments, such as plasma exchange (which can reduce cord perfusion) [27] [28] [29] and intravenous immunoglobulin (which is prothrombotic), [30] [31] [32] could be harmful and should be avoided. Aggressive rehabilitation should be pursued, 1 and many patients achieve a good outcome (47% without gait aid).
Limitations
Our study is limited by its retrospective design. The absence of a criterion standard for diagnosis of spontaneous SCI against which our diagnostic criteria can be assessed is the main limitation. The possibility exists that some cases with alternative myelopathy etiologies were misdiagnosed as SCI. The exhaustive workup undertaken to exclude alternative etiologies helped reduce this risk of misdiagnosis. Patients did not receive a standard battery of tests in all cases. Forty-six patients were excluded because they had incomplete data and thus did not meet inclusion criteria. The predominance of white individuals likely reflects our upper Midwest patient catchment area, which is also predominantly white (80%-90%) and impacts the generalizability to other racial/ethnic groups. 33 The imaging sequences performed varied, as did their timing. A larger number of patients with DWI may change the apparent sensitivity, but the absence of diffusion restriction does not exclude SCI as shown in the periprocedural setting. 2 Validation of these criteria will be needed in other cohorts and ideally would include greater racial/ethnic diversity.
Conclusions
In conclusion, our comprehensive review of a large series of patients with SCI identified several clinical and radiological clues to SCI and refines our understanding of the spectrum of SCI presentation. We proposed and validated a set of diagnostic criteria that may improve recognition of SCI cases, guide acute management, and facilitate future research.
eBox 1. Alternative acute myelopathy diagnoses
Abbreviations: AQP4, aquaporin-4; DAVF, dural arteriovenous fistula; HIV, human immunodeficiency virus; IgG, immunoglobulin G; MOG, myelin oligodendrocyte glycoprotein; NMOSD, neuromyelitis optica spectrum disorders.
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